Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

Nimodipine

SKU: orb1224312

Description

Nimodipine(Nimotop) is a dihydropyridine derivative and an analogue of the calcium channel blocker nifedipine, with antihypertensive activity.Nimodipine decreases intracellular free Ca2+,Beclin-1 and autophagy.(In Vitro):Nimodipine (1.5~150 μg/ml; 15 minutes; B16a and W256 cells) results in a dose-dependent inhibition of B16a and W256 tumor-cell-induced platelet aggregation. Nimodipine is also inhibitory in a homologous system.(In Vivo):Nimodipine (0.2 μg/μl, intrathecal administration) prevents subarachnoid hemorrhage-associated cerebral vasospasm by prophylactic continuous intrathecal administration.Nimodipine(0.1~80 mg/kg; p.o.) results in a significant dose-dependent inhibition of spontaneous metastasis.

Research Area

Pharmacology & Drug Discovery

Images & Validation

Key Properties

CAS Number66085-59-4
MW418.44
Purity>98% (HPLC)
FormulaC21H26N2O7
SMILESCC1=C(C(OCCOC)=O)C(C2=CC([N+]([O-])=O)=CC=C2)C(C(OC(C)C)=O)=C(C)N1
TargetAhR
SolubilityEthanol: 84 mg/mL (200.74 mM); DMSO: 84 mg/mL (200.74 mM)

Bioactivity

In Vivo
Nimodipine (0.2 μg/μl, intrathecal administration) prevents subarachnoid hemorrhage-associated cerebral vasospasm by prophylactic continuous intrathecal administration. Nimodipine(0.1~80 mg/kg; p.o.) results in a significant dose-dependent inhibition of spontaneous metastasis. Animal model: New Zealand white rabbits. Dosage: 0.2 μg/μl. Administration: Intrathecal administration. Result: Prevented subarachnoid hemorrhage-associated cerebral vasospasm by prophylactic continuous intrathecal administration.
In Vitro
Nimodipine (1.5~150 μg/ml; 15 minutes; B16a and W256 cells) results in a dose-dependent inhibition of B16a and W256 tumor-cell-induced platelet aggregation. Nimodipine is also inhibitory in a homologous system.

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

Admon | BAY-e 9736 | Periplum

Similar Products

  • Nimodipine [orb1310704]

    >98%

    66085-59-4

    418.44

    C21H26N2O7

    100 mg, 500 mg
  • (R)-Nimodipine [orb3181102]

    77940-92-2

    418.45

    C21H26N2O7

    50 mg, 10 mg
  • (S)-Nimodipine [orb3181565]

    77940-93-3

    418.45

    C21H26N2O7

    50 mg, 10 mg
  • Cilnidipine [orb1226543]

    >98% (HPLC)

    132203-70-4

    492.5204

    C27H28N2O7

    10 mg, 50 mg, 100 mg, 200 mg, 500 mg, 1 g
  • GALNON TFA(475115-35-6(free base)) [orb1219885]

    5 mg, 50 mg, 100 mg, 200 mg, 500 mg, 1 g, 10 mg, 25 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

Nimodipine (orb1224312)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

50 mg
$ 80.00
100 mg
$ 90.00
500 mg
$ 130.00